Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Sakai Chemical Industry Co Ltd

Sakai Chemical Industry Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.

  • Revenue in JPY (TTM)--
  • Net income in JPY--
  • Incorporated1932
  • Employees2.00k
  • Location
    Sakai Chemical Industry Co Ltd5-2, Ebisujima-cho, Sakai-kuSAKAI-SHI 590-8502JapanJPN
  • Phone+81 722234111
  • Fax+81 722238355
  • Websitehttps://www.sakai-chem.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.